Senti Biosciences replaces KPMG with KNAV as auditor
SNTI•Senti Biosciences dismissed KPMG effective Nov. 17, 2026, and selected KNAV CPA on Nov. 20 to audit its fiscal year ending Dec. 31, 2026. KPMG’s 2024 and 2025 reports cited substantial doubt about the company’s ability to continue as a going concern.
1. Auditor change
Senti Biosciences Holdings dismissed KPMG as its independent auditor effective Nov. 17, 2026. Its audit committee selected KNAV CPA on Nov. 20 as auditor for the fiscal year ending Dec. 31, 2026.
2. Prior audit findings
KPMG’s audit reports for 2024 and 2025 flagged substantial doubt about the company’s ability to continue as a going concern. No accounting disagreements arose during those years or through Nov. 17, 2026. A material weakness involving insufficient finance and accounting resources existed at Dec. 31, 2024; management concluded it was remediated during 2025.




